Faster-acting insulin aspart
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Faster-acting insulin aspart, covering 2018-07-24 to 2019-04-04. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes [Phase 3]